Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, acti

First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris

(2011) Keisuke NAKASE et al.   JOURNAL OF DERMATOLOGY

Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin

(2010) Neelam Muizzuddin et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris

(2009) Matt Sagransky et al.   EXPERT OPINION ON PHARMACOTHERAPY

New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group

(2009) Diane Thiboutot et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability

(2009) H-C Ko et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Antimicrobial susceptibilities ofPropionibacterium acnesisolated from patients with acne vulgaris

(2008) Natsumi Ishida et al.   MICROBIOLOGY AND IMMUNOLOGY

Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: A randomized, multicenter, investigator-blinded, controlled study

(2007) Makoto Kawashima et al.   JOURNAL OF DERMATOLOGICAL SCIENCE